Highlights in International Tobacco Giants' Financial Reports for 2023FY

Industry Insight by 2FIRSTS, edited by Sophia
Feb.28.2024
Highlights in International Tobacco Giants' Financial Reports for 2023FY
BAT, PMI, and JTI release Q4 and annual financial reports for 2023, highlighting performance and future strategies in new tobacco.

In early February, British American Tobacco (BAT), Philip Morris International (PMI), and Japan Tobacco International (JTI) each released their financial reports for the fourth quarter and full year of 2023. The reports included a review and disclosure of their performance for the year, as well as a partial unveiling of the Annual Operation Plan for the upcoming fiscal year.

 

Based on the financial reports, 2FIRSTS conducted a review and analysis of the performance and future development strategies of three international tobacco companies in the new tobacco sector in 2023.

 

 

IQOS Continues to Lead in Shipment Volume of NTPs, BAT Demonstrates Outstanding Profitability

 

Three international tobacco companies have given different names to their new tobacco businesses. For example, BAT refers to it as "New categories" (NC), which includes vaping, HNB, and oral products; while PMI calls it Heated Tobacco Units (HTU) and JTI refers to it as "Reduced-Risk Products" (RRP).

 

In a comparative analysis of three international tobacco companies, in 2023, the unit shipments of PMI were 125.2 billion, surpassing those of BAT at 29.7 billion and JTI at 8.8 billion. PMI's new tobacco product volume is three times greater than the combined total of BAT and JTI, giving it a significant competitive advantage.

 

The new tobacco segment of three international tobacco companies saw varying increases in shipments in 2023. PMI recorded a 14.7% increase, JTI recorded an 11.8% increase, and BAT recorded the smallest increase of 3.8% among the three.

 

Noteworthy is the decrease in BAT's heated tobacco products (HTP) recorded report, at -1.3%. The growth was mainly driven by aerosol products (7%) and oral/dissolvable products (33.6%); despite slow growth in shipment volume, the increase in revenue far exceeded this, with NC's organic revenue growth reaching 21.0%. The unit profitability is worth noting.

 

BAT: VUSE Drives "New Category", Calling for U.S. to Strengthen Compliant Markets

 

BAT released its 2023 financial report on February 8, showing a 1.3% overall decrease in revenue for the BAT group, offset by a 21.0% increase in organic revenue from "new categories." According to BAT, this strong momentum was driven by sales of Vuse and Velo.

 

The new category products performed well in different regional markets. In the traditionally strong BAT market of Europe and America (AME), the profits from the new category reached £1.67 billion. Meanwhile, the emerging markets in Asia Pacific, Middle East, and Africa (APMEA) also showed strong performance, with profits reaching £610 million.

 

In 2023, revenue from non-combustible products now accounts for 16.5% of BAT Group's income. In their financial report, BAT stated that "vape is the fastest-growing smoking alternative, with Vuse leading the global market for vape products, and described glo as the No.2 player in the HNB sector." Velo was labeled as "the least harmful product in the new category."

 

Highlights in International Tobacco Giants' Financial Reports for 2023FY
British American Tobacco positions its various product lines under its new tobacco division | Image source: British American Tobacco 2024 financial report

 

In the business of BAT, new categories have now become strong enough to offset the lackluster performance of the combustible segment. The group is expected to deepen its new tobacco layout in the foreseeable future, especially in its strategically advantageous compliant markets. In its financial report, BAT specifically pointed out that the group "welcomes the increased enforcement efforts by the US Food and Drug Administration (FDA) and other federal and state government agencies, taking more measures to prevent the illegal sale of flavored disposable e-cigarettes in the United States," urging the FDA and other agencies to accelerate market compliance in the United States to maximize its compliance advantage and strengthen market share.

 

PMI: Sluggish Growth in Shipments of IQOS, which will Undergo Test Run in U.S. in 2024

 

On the other hand, PMI, which also released its financial report on February 8, announced the impressive performance of its new tobacco products. In 2023, PMI's IQOS user base is estimated to be around 28.6 million, an increase of 3.7 million compared to December 2022. IQOS's market share in the HNB market increased by 1.2% for the full year, reaching 9.1%. CEO Jacek Olczak stated that IQOS's net revenue has exceeded that of classic cigarette brand Marlboro in this fiscal year.

 

However, even though income has surpassed, the shipment growth of IQOS has begun to slow down after years of rapid growth, causing concern among observers. Throughout the year 2023, the entire heated tobacco segment of PMI saw a growth rate of 14.7%, compared to 14.9% in 2022, showing a slight overall decline; PMI stated that the slowdown is mainly due to the EU's ban on flavored heated tobacco, and they forecast that shipment volumes in 2024 will be further impacted.

 

Highlights in International Tobacco Giants' Financial Reports for 2023FY
Comparison of PMI's heated tobacco and cigarette performance | Source: PMI 2024 financial report

 

However, Alzack remains optimistic about the future performance of the group's new tobacco products. In a statement, he said the company is "entering 2024 with strong momentum." As of December 31, 2023, PMI's smoke-free products were being sold in 84 markets. In the past year, the amortization of intangible assets acquired by PMI amounted to $0.42 per share, including the agreement reached with Altria on the commercialization rights of IQOS in the United States, which will come into effect on May 1, 2024. By then, IQOS will also officially "test the waters" in the United States about a decade after its initial launch.

 

The American market, which has been "educated" by vaping for many years, is now eagerly anticipating how it will receive HNB products, making it one of the most closely watched trends in the industry for the coming year.

 

JT: Increased Investment in Ploom and Continued Expansion of International Market for HTPs

 

At the same time, JT, which released its financial report later on February 13, reported that in the past fiscal year 2023, JT Group's performance reached record levels across all financial indicators. JT attributed its outstanding performance to "growth in market share in Japan" and "marketing efforts driving sales growth".

 

According to the financial report, over the past year, positive changes in trading volume have been driven by the growth in market share of Ploom X in Japan, especially as Ploom continues to increase its market share. The release of the Ploom X ADVANCED in November further enhanced consumer adoption and retention, leading to a continued increase in market share in the increasingly competitive field of heated tobacco systems (HTS) in Japan, reaching 11.4%.

 

Meanwhile, over the past year, JT has continuously expanded the geographical coverage of its HNB product Ploom X. By the end of 2023, Ploom X had entered 13 markets; in Japan, JT Group's market share in the heated tobacco segment reached 11.4% in December 2023.

 

It is worth noting that among the three major international tobacco companies, JTI is the only company that saw an increase in sales of combustible cigarettes. According to Bloomberg, the company manufactured and shipped over 531 billion combustible cigarettes last year, with a total sales volume increase of 2.3% for JTI's Winston and Camel brands in 2023. In comparison, PMI's cigarette shipments in 2023 were 613 billion, a decrease of 1.3% from the previous year; while BAT's shipments were 555 billion, an 8.2% decrease from 2022.

 

The difference in sales highlights the strategic and priority differences within JTI. While PMI and BAT are directing more research and marketing resources towards alternative products including e-cigarettes, heated tobacco, and nicotine pouches, JTI appears to be more focused on trying to increase market share and sales in traditional cigarettes. However, the group still announced in its financial report that it will increase investments in heated tobacco, including Ploom. According to the financial report, JT's target is to cover approximately 80% of global HTS demand by the end of 2025, and they plan to introduce Ploom X into over 40 markets globally by the end of 2026.

 

Highlights in International Tobacco Giants' Financial Reports for 2023FY
Ploom Performance Targets | Image source: Japan Tobacco 2024 Financial Report

 

In response, Duncan Fox, an analyst at the Bloomberg Intelligence, pointed out that increasing investment in Ploom "is reasonable, but if it is to overcome established competition, it may be too late." He mentioned that the conversion of this investment will take time and projected that "JT's operating profit will decline in 2024," while "Ploom will not achieve profitability until 2028."

 

2FIRSTS will continue to monitor the latest developments from major tobacco companies in the new year.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
Pennsylvania Vape Directory Law Survives Court Challenge From Nova Distro and Others Amid Similar Rulings Across States
A U.S. federal court upheld Pennsylvania's vape directory law on October 14, rejecting a challenge brought by Nova Distro, 101 Distributors and companies operating Tobacco Hut retail stores. Court records show that vaping accounts for about 60% of Tobacco Hut's profits and that the chain held approximately $2 million in inventory potentially subject to seizure under the law as of June 2. Pennsylvania began enforcement on October 19. The ruling follows similar appellate decisions in other states, even as new research shows that unlisted vaping products continue to account for substantial sales in states with established directories.
Regulations
Oct.22
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Couche-Tard Posts Double-Digit U.S. Same-Store Growth in Other Nicotine Products, Led by Pouches
Alimentation Couche-Tard said U.S. same-store sales in its “other nicotine products” category grew at a double-digit rate in the first quarter of fiscal 2027, led by nicotine pouches, while overall U.S. same-store merchandise revenues increased 1.7%. The company also said its Canadian nicotine business continued to face regulatory pressure and illicit-market headwinds. The U.S. performance coincides with Couche-Tard's participation in efforts to reopen Canadian convenience-store access to authorized nicotine pouches, though the company has not established a direct causal link between the two.
Sep.14
Sweden Finds ZYN Ingredient Labels Noncompliant Over Generic Flavoring Disclosure, Swedish Match Faces SEK 2 Million Monthly Penalty
Sweden Finds ZYN Ingredient Labels Noncompliant Over Generic Flavoring Disclosure, Swedish Match Faces SEK 2 Million Monthly Penalty
Sweden's Public Health Agency has found ingredient labels on ZYN nicotine pouches sold by Philip Morris International subsidiary Swedish Match to be noncompliant, according to Dagens industri. The products' packaging listed 10 to 13 ingredients, compared with 11 to 42 in regulatory submissions, with multiple flavoring ingredients grouped under the generic term "aromer." The agency ordered corrective action, warning of a conditional penalty of SEK 2 million per month for noncompliance. The order applies only to products manufactured after the decision becomes legally effective and does not require recalls. Swedish Match disputes the agency's interpretation and plans to appeal.
PMI
Oct.22
Turning Point Brands Q3 Modern Oral Net Sales Rise 103% to $74.4 Million as Attributable Profit Falls 81%
Turning Point Brands Q3 Modern Oral Net Sales Rise 103% to $74.4 Million as Attributable Profit Falls 81%
Turning Point Brands (TPB) reported third-quarter 2026 Modern Oral net sales of $74.4 million on November 9, up 102.9% year over year and representing 49.2% of consolidated net sales. Total company net sales rose 27.0% to $151.1 million, while net income attributable to TPB declined 81.4% to $3.93 million. The company is expanding the US retail presence of its FRE and ALP nicotine pouch brands and expects its Modern Oral chain-store footprint to grow by more than 70% during 2026. Selling, general and administrative expenses increased 69.1% to $75.3 million, while PMTA-related expenses reached approximately $3.15 million and manufacturing start-up costs totaled about $593,000. ALP plans to open a branded pop-up in New York City's SoHo neighborhood on November 13, alongside a marketing campaign extending into January 2027. TPB owns 50% of ALP but consolidates the venture in its financial statements.
company
Nov.11
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
Product | BAT Launches VELO WRKS Nicotine Pouches in Sweden, Introducing Dual-Compartment Cans With Two Flavours
British American Tobacco (BAT)'s VELO brand launched the VELO WRKS nicotine pouch range in Sweden on November 2, 2026. The initial release features three Dual Can variants, each containing two separate flavours in a dual-compartment container. Each can holds 20 slim pouches with 8mg of nicotine per pouch and retails for SEK 52.99. According to VELO, the first release, Drop 1, is limited to 75,000 cans and will remain available until February 2027 or while stocks last. VELO positions WRKS as a platform for testing new product concepts and has introduced an online consumer feedback survey. EU trademark records show BAT applied to register VELO WRKS in March 2026 under Class 34, covering nicotine pouches, e-cigarettes, heated tobacco products and other tobacco-related goods.
product
Nov.03
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's Tobacco Plan Excludes 6-Methyl Nicotine as Customs Tightens Import Controls and Analog Liquid Imports Fall 83%
South Korea's government unveiled its first Tobacco Harm Management Basic Plan for 2027–2031 on October 29, 2026, proposing broader testing of vaping and heated tobacco products while excluding nicotine analogs such as 6-methyl nicotine. Synthetic nicotine came under tobacco regulation on April 24, and a June investigation found 6-methyl nicotine in 12 liquid inhalation products marketed as nicotine-free. Customs data released in September showed that imports of nicotine analog solutions fell 83.3%, from 12 metric tons in January–April to 2 metric tons in May–August. By September 20, imports had reached approximately 15 metric tons for the year, with 99.99% originating from China. Customs authorities have tightened pre-clearance testing and supply-chain documentation requirements, while the MFDS expects to complete its assessment of nicotine analog hazards by the end of 2026.
Regulations
Nov.04